Prenatal and New-born Genetic Testing Market : Non-invasive Methods Have High Market Demand

Genetic testing is a systematic diagnostic and screening technique usually applied to detect risk of genetic disorders in unicellular and multicellular organisms. This technique coversan array of techniques that includes analysis of human DNA, RNA, or protein. Genetic testing is broadly segmented as newborn screening, diagnostic testing, carrier testing, prenatal testing, pre-implantation testing, predictive and forensic testing.

Its importance is also increasing significantly in prenatal and newborn testing where screening/diagnostic procedures are utilized to detect chromosomal abnormalities such as Down syndrome, Patau syndrome, Edward syndrome and others ina fetus or new born baby.According to Northwestern Medical Faculty Foundation, Down syndrome, open neural tube defects and trisomy 18 are the birth defects that 85% of women are advised to be screened or tested for during pregnancy. Whereas, there are some tests which also provide information about trisomy 13 and other chromosome abnormalities.

Browse Full Report Prenatal and New-born Genetic Testing Market with TOC @ http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html

The prenatal and newborn genetic testing market is observing a significant growth with increasing maternal age and late pregnancies, technological advancements and growing awareness about genetic disorders in the fetus. One of the important factors hindering this growth is falling fertility rate which is claimed to be a global concern, as most developed countries are facing this problem. It was also observed that the prenatal and newborn genetic testing market is still at a nascent stage and has many opportunities such as capitalizing on potential markets in the emerging Asian, African and Latin American countries.

The prenatal and newborn genetic testing market by technology is broadly segmented as diagnostic tests and screening methods. The diagnostic tests segment covers the global market for techniques such as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH), while screening methods include non-invasive prenatal testing (NIPT) and maternal serum screening (MSS).Diagnostic methods are more effective, accurate and a preferred option for the detection of chromosomal abnormalities as compared to screening methods. In 2012, PCR accounted for the highest market share of the total market of prenatal and newborn genetics testing, while non-invasive prenatal testing (NIPT) is expected to show significant growth during the forecast period of 2013 to 2019.

Transparency Market Research, a leading U.S. based market research firm analyses the global market for prenatal and newborn genetic testing and predicts a CAGR of 26.9% for the period 2013-2019.Withinthe diagnostic testing market, PCR technique is the largest market, while array comparative genomic hybridization (aCGH) has the highest growth rate. Screening tests include NIPT and MSS, where NIPT is the largest market and is growing with the highest CAGR during the forecast period of 2013 to 2019 compared to MSS, because MSS tests carry risk of miscarriage while NIPTs are at a low risk for the same.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1744

The North American region accounted for the largest prenatal and newborn genetic testing market and is expected to grow at the highest CAGR during the forecast period of 2013 to 2019. Europe is the second largest market covering major market share from the global market. One of the key factors driving the growth of North American and European markets isthe non-invasive nature of the tests that completely eliminates the risk of miscarriage associated with invasive tests such as amniocentesis and Chorionic Villus Sampling(CVS). Rest of the World (RoW) is observed to be the untapped market having lowest share of the global market but is estimated to grow at an accountable growth rateduring the forecast period of 2013 to 2019. Overall, Asia-Pacific and RoW are observed to be the upcoming destinations for exploration and expansion of the prenatal and newborn genetic testing market.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.